Archives

by in
Entry Author Date Location
The Risks and Opportunities in a Startup: Age 2-5 Years 11/24/14 San Francisco
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Seattle Roundup: AWS to Clean Cloud, Pitch Winners, Techstars, & More 11/21/14 Seattle
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Seattle’s Fred Hutch Taps a Harvard, Merck Vet As New President 11/20/14 Seattle
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray 11/18/14 Boston
Breaking Bottlenecks, Opening the Floodgates to Genomic Data 11/18/14 National
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
Leading Seattle Entrepreneurs to Share Stories at Xconomy Xchange Tuesday 11/14/14 Seattle
Innovation Hub: The Next Wave of Sports Analytics 11/14/14 National
Rival IQ Garners $1,000,000 New Funding Round 11/14/14 Seattle
Indice Semiconductor Garners $6,000,000 New Financing Round 11/14/14 Seattle
Dissecting the “Dataware” Technology Stack with Madrona’s Matt McIlwain 11/13/14 Seattle
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
Who Needs a Mega-Hit? 12-Year-Old Big Fish Games Sold for $885M 11/13/14 Seattle
Ballmer Pumps Life into Boston Tech Ecosystem with Harvard Grant 11/13/14 Boston
Entomo Secures $2,000,000 New Funding 11/13/14 Seattle
know’N’act Lands $500,000 New Round 11/13/14 Seattle
Jane Says: Julep CEO on Leadership, Growing Pains, Community, Family 11/12/14 Seattle
Next-Gen Network Monitoring: The Missing Piece of the Security Puzzle 11/12/14 Seattle
With Wires and Electrodes, Tara Bio Builds a Heart on a Chip 11/12/14 New York
Lowering the Cost of Failure in Biopharmaceuticals 11/11/14 Boston
Avalara Lands $100,000,000 New Financing Round 11/11/14 Seattle
Good Done Great Obtains $500,000 New Round 11/11/14 Seattle
Sales-Tax Software Seller Avalara Adds $100M from Warburg Pincus 11/10/14 Seattle
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
Beg, Borrow, or Steal: Accessing Unaffordable Science Journals 11/10/14 National
Highspot Obtains $9,600,000 Series A Financing 11/10/14 Seattle
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
Page 1 of 260 next page »